Nutraceutical Files For Appellate Court Rehearing Of Ephedra Ban Suit
This article was originally published in The Tan Sheet
Executive Summary
The appellate court decision that upheld FDA's 2004 ephedra ban overextends the agency's authority and blurs the line between food and drug regulation, attorneys for marketer Nutraceutical say in a request for rehearing